Activity ratios measure how efficiently a company performs day-to-day tasks, such us the collection of receivables and management of inventory.
Short-term Activity Ratios (Summary)
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
The company maintains a consistently negative cash conversion cycle throughout the analyzed period, indicating a highly efficient working capital strategy. This suggests that the organization recovers cash from its sales and inventory movements more quickly than it is required to pay its suppliers, effectively using trade credit as a source of operational financing.
- Inventory Management
- Inventory turnover shows relative stability with a slight peak in 2019 at 15.77, followed by a moderate decline and a subsequent recovery to 14.80 in 2022. The average inventory processing period remained consistent, fluctuating within a narrow range of 23 to 28 days, reflecting a steady rate of inventory throughput.
- Receivables Management
- A gradual downward trend in receivables turnover is observed, decreasing from 14.86 in 2017 to 12.93 in 2022. This decline is mirrored by an increase in the average receivable collection period, which expanded from 25 days to a peak of 31 days in 2021 before settling at 28 days in 2022, suggesting a slight lengthening of the time required to collect payments from customers.
- Payables Management
- Payables turnover remained remarkably stable, oscillating between a high of 6.15 and a low of 5.45. The average payables payment period consistently stayed between 59 and 67 days. This extended payment window is a primary driver of the company's liquidity position, as it significantly exceeds the duration of the inventory and collection cycles.
- Operating and Cash Conversion Cycles
- The operating cycle experienced minor volatility, ranging from a low of 48 days in 2019 to a high of 58 days in 2021. Despite these shifts, the cash conversion cycle remained negative, ranging from -8 to -11 days. This negative value confirms that the company operates with a structural liquidity advantage, where supplier credit offsets the cash tied up in receivables and inventory.
AI Ask an analyst for more
Turnover Ratios
Average No. Days
Inventory Turnover
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Cost of goods sold | 230,290,639) | 207,045,615) | 184,702,042) | 174,450,809) | 163,327,318) | 148,597,824) | |
| Inventories | 15,556,394) | 15,368,352) | 12,589,278) | 11,060,254) | 11,918,508) | 11,461,428) | |
| Short-term Activity Ratio | |||||||
| Inventory turnover1 | 14.80 | 13.47 | 14.67 | 15.77 | 13.70 | 12.97 | |
| Benchmarks | |||||||
| Inventory Turnover, Competitors2 | |||||||
| Abbott Laboratories | 3.10 | 3.59 | — | — | — | — | |
| Intuitive Surgical Inc. | 2.27 | 2.98 | — | — | — | — | |
| Medtronic PLC | 2.20 | 2.43 | — | — | — | — | |
| Inventory Turnover, Sector | |||||||
| Health Care Equipment & Services | 30.70 | 31.85 | — | — | — | — | |
| Inventory Turnover, Industry | |||||||
| Health Care | 7.85 | 7.90 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Inventory turnover = Cost of goods sold ÷ Inventories
= 230,290,639 ÷ 15,556,394 = 14.80
2 Click competitor name to see calculations.
An analysis of operating activity between 2017 and 2022 reveals a consistent expansion in business volume, characterized by a steady increase in the cost of goods sold. Total cost of goods sold grew from approximately 148.6 billion USD in 2017 to 230.3 billion USD in 2022, reflecting a sustained upward trajectory in the volume of products moved through the supply chain.
- Cost of Goods Sold Trends
- A continuous year-over-year increase in the cost of goods sold is observed throughout the period. This growth indicates a significant scaling of operations, with the most substantial nominal increases occurring between 2020 and 2022.
- Inventory Level Dynamics
- Inventory levels remained relatively stable from 2017 through 2019, hovering near 11 billion USD. A shift occurred in 2020, leading to a marked increase in holdings that peaked at 15.5 billion USD in 2022. The most pronounced growth in inventory occurred between 2020 and 2021, suggesting a strategic increase in stock levels or responses to supply chain volatility.
- Inventory Turnover Performance
- The inventory turnover ratio demonstrated a non-linear trend, peaking at 15.77 in 2019, which represents the highest efficiency in inventory conversion during the period. This was followed by a two-year decline, reaching a low of 13.47 in 2021, coinciding with the aforementioned increase in total inventory. A recovery was observed in 2022, with the ratio rising to 14.80, indicating a return toward higher operational efficiency and more rapid stock rotation.
AI Ask an analyst for more
Receivables Turnover
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Revenue | 238,587,006) | 213,988,843) | 189,893,926) | 179,589,121) | 167,939,635) | 153,143,826) | |
| Accounts receivable, less allowances for returns and credit losses | 18,452,675) | 18,167,175) | 13,846,301) | 12,386,879) | 11,314,226) | 10,303,324) | |
| Short-term Activity Ratio | |||||||
| Receivables turnover1 | 12.93 | 11.78 | 13.71 | 14.50 | 14.84 | 14.86 | |
| Benchmarks | |||||||
| Receivables Turnover, Competitors2 | |||||||
| Abbott Laboratories | 7.02 | 6.64 | — | — | — | — | |
| Elevance Health Inc. | 18.81 | 20.66 | — | — | — | — | |
| Intuitive Surgical Inc. | 6.60 | 7.30 | — | — | — | — | |
| Medtronic PLC | 5.71 | 5.51 | — | — | — | — | |
| UnitedHealth Group Inc. | 18.22 | 20.07 | — | — | — | — | |
| Receivables Turnover, Sector | |||||||
| Health Care Equipment & Services | 14.33 | 14.76 | — | — | — | — | |
| Receivables Turnover, Industry | |||||||
| Health Care | 8.22 | 8.00 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Receivables turnover = Revenue ÷ Accounts receivable, less allowances for returns and credit losses
= 238,587,006 ÷ 18,452,675 = 12.93
2 Click competitor name to see calculations.
A comprehensive analysis of the operating activity indicates a steady increase in revenue from 2017 to 2022, growing from 153,143,826 thousand to 238,587,006 thousand. While revenue growth remained consistent, the growth in accounts receivable outpaced this expansion over the six-year period, resulting in a general downward trend in the receivables turnover ratio until a partial recovery in the final year.
- Revenue and Receivables Correlation
- Between 2017 and 2022, revenue increased by approximately 55.8%, while accounts receivable, less allowances, rose by approximately 79.1%. The disproportionate growth of receivables relative to sales suggests a lengthening of the cash conversion cycle over the observed period.
- Receivables Turnover Trend
- The turnover ratio remained relatively stable between 2017 and 2018, moving from 14.86 to 14.84. A persistent decline followed, with the ratio dropping to 14.50 in 2019 and 13.71 in 2020. The most significant contraction occurred in 2021, when the ratio reached a period low of 11.78.
- Analysis of the 2021 Contraction
- The sharp decline in the turnover ratio in 2021 is closely linked to a substantial increase in accounts receivable, which jumped from 13,846,301 thousand in 2020 to 18,167,175 thousand in 2021. This suggests a period of slower collections or a strategic shift in credit terms extended to customers during that fiscal year.
- Recent Recovery and Efficiency
- In 2022, the receivables turnover ratio improved to 12.93. This upward movement, despite a continued absolute increase in accounts receivable to 18,452,675 thousand, indicates that revenue growth for the period (increasing to 238,587,006 thousand) began to outpace the growth of receivables, signaling an improvement in collection efficiency compared to 2021.
AI Ask an analyst for more
Payables Turnover
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Cost of goods sold | 230,290,639) | 207,045,615) | 184,702,042) | 174,450,809) | 163,327,318) | 148,597,824) | |
| Accounts payable | 40,192,890) | 38,009,954) | 31,705,055) | 28,385,074) | 26,836,873) | 25,404,042) | |
| Short-term Activity Ratio | |||||||
| Payables turnover1 | 5.73 | 5.45 | 5.83 | 6.15 | 6.09 | 5.85 | |
| Benchmarks | |||||||
| Payables Turnover, Competitors2 | |||||||
| Abbott Laboratories | 4.15 | 4.21 | — | — | — | — | |
| Elevance Health Inc. | 7.47 | 7.59 | — | — | — | — | |
| Intuitive Surgical Inc. | 13.78 | 14.45 | — | — | — | — | |
| Medtronic PLC | 4.46 | 4.98 | — | — | — | — | |
| UnitedHealth Group Inc. | 7.26 | 7.63 | — | — | — | — | |
| Payables Turnover, Sector | |||||||
| Health Care Equipment & Services | 6.94 | 7.18 | — | — | — | — | |
| Payables Turnover, Industry | |||||||
| Health Care | 5.79 | 5.84 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Payables turnover = Cost of goods sold ÷ Accounts payable
= 230,290,639 ÷ 40,192,890 = 5.73
2 Click competitor name to see calculations.
An analysis of the operating activity ratios from September 30, 2017, to September 30, 2022, reveals a consistent expansion in the scale of procurement and credit utilization. Both the cost of goods sold and accounts payable exhibited uninterrupted annual growth over the six-year period. The cost of goods sold increased from approximately 148.6 billion US dollars in 2017 to 230.3 billion US dollars in 2022, representing a significant growth in operational volume.
- Payables Turnover Dynamics
- The payables turnover ratio remained relatively stable, fluctuating within a narrow range between 5.45 and 6.15. A gradual increase was observed from 2017 to 2019, peaking at 6.15. This was followed by a downward trend that reached its lowest point of 5.45 in 2021, before recovering slightly to 5.73 in 2022. The decline observed between 2019 and 2021 suggests a strategic extension of payment terms or an increase in the average time taken to settle obligations with suppliers.
- Correlation Between COGS and Payables
- Accounts payable grew from 25.4 billion US dollars in 2017 to 40.2 billion US dollars in 2022. While both costs of goods sold and payables increased, the growth in payables slightly outpaced the growth in turnover in the later years of the period. This indicates a high capacity to leverage supplier credit to fund the growth in inventory and sales volume.
- Operational Efficiency Insights
- The relative stability of the turnover ratio despite the massive increase in absolute dollar values suggests a disciplined approach to working capital management. The slight recovery in the turnover ratio in 2022 suggests a return toward previous payment patterns following the dip observed in 2021.
AI Ask an analyst for more
Working Capital Turnover
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | |||||||
| Current assets | 39,589,758) | 38,802,609) | 33,055,702) | 28,132,054) | 25,894,372) | 24,303,299) | |
| Less: Current liabilities | 43,477,955) | 41,358,641) | 33,853,077) | 29,581,294) | 27,869,687) | 26,818,165) | |
| Working capital | (3,888,197) | (2,556,032) | (797,375) | (1,449,240) | (1,975,315) | (2,514,866) | |
| Revenue | 238,587,006) | 213,988,843) | 189,893,926) | 179,589,121) | 167,939,635) | 153,143,826) | |
| Short-term Activity Ratio | |||||||
| Working capital turnover1 | — | — | — | — | — | — | |
| Benchmarks | |||||||
| Working Capital Turnover, Competitors2 | |||||||
| Abbott Laboratories | 4.48 | 3.87 | — | — | — | — | |
| Elevance Health Inc. | 8.37 | 7.23 | — | — | — | — | |
| Intuitive Surgical Inc. | 1.29 | 1.22 | — | — | — | — | |
| Medtronic PLC | 2.97 | 2.15 | — | — | — | — | |
| UnitedHealth Group Inc. | — | — | — | — | — | — | |
| Working Capital Turnover, Sector | |||||||
| Health Care Equipment & Services | 25.59 | 16.28 | — | — | — | — | |
| Working Capital Turnover, Industry | |||||||
| Health Care | 11.30 | 8.57 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Working capital turnover = Revenue ÷ Working capital
= 238,587,006 ÷ -3,888,197 = —
2 Click competitor name to see calculations.
Analysis of the short-term operating activity reveals a consistent growth pattern in revenue alongside a persistent negative working capital position from 2017 through 2022.
- Revenue Performance
- A steady upward trajectory in revenue is observed, increasing from 153,143,826 thousand US dollars in 2017 to 238,587,006 thousand US dollars in 2022. This continuous expansion indicates a significant growth in the scale of operations over the six-year period.
- Working Capital Trends
- Working capital remained negative throughout the entire analyzed period, a condition often associated with high-volume distribution models that leverage supplier credit. The deficit narrowed progressively from 2017 to 2020, reaching its minimum negative value of 797,375 thousand US dollars in 2020. However, this trend reversed sharply in the final two years, with the negative balance widening to 3,888,197 thousand US dollars by September 30, 2022.
- Working Capital Turnover Analysis
- The working capital turnover ratio exhibits volatility due to the fluctuating negative working capital base. Between 2017 and 2020, the narrowing of the negative working capital relative to growing revenues led to an increase in the magnitude of the turnover ratio. Conversely, the substantial increase in the negative working capital position during 2021 and 2022 offset the revenue gains, resulting in a turnover ratio that aligns more closely with the levels observed at the beginning of the period. This suggests an increased reliance on short-term liabilities to fund the accelerated growth in revenue observed in the later years.
AI Ask an analyst for more
Average Inventory Processing Period
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Inventory turnover | 14.80 | 13.47 | 14.67 | 15.77 | 13.70 | 12.97 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average inventory processing period1 | 25 | 27 | 25 | 23 | 27 | 28 | |
| Benchmarks (no. days) | |||||||
| Average Inventory Processing Period, Competitors2 | |||||||
| Abbott Laboratories | 118 | 102 | — | — | — | — | |
| Intuitive Surgical Inc. | 161 | 122 | — | — | — | — | |
| Medtronic PLC | 166 | 150 | — | — | — | — | |
| Average Inventory Processing Period, Sector | |||||||
| Health Care Equipment & Services | 12 | 11 | — | — | — | — | |
| Average Inventory Processing Period, Industry | |||||||
| Health Care | 46 | 46 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Average inventory processing period = 365 ÷ Inventory turnover
= 365 ÷ 14.80 = 25
2 Click competitor name to see calculations.
The analysis of short-term operating activity reveals a consistent pattern of high inventory velocity with moderate fluctuations over the six-year period ending September 30, 2022. The inverse relationship between inventory turnover and the average processing period indicates a stable operational capacity to manage stock levels relative to sales volume.
- Inventory Turnover
- An upward trajectory was observed between 2017 and 2019, with the turnover ratio increasing from 12.97 to a peak of 15.77. This indicates an acceleration in the rate at which inventory was cycled. Following this peak, the ratio experienced a contraction, reaching a low of 13.47 in 2021, before recovering to 14.80 by the end of the 2022 fiscal year.
- Average Inventory Processing Period
- The time required to process inventory exhibited a corresponding decrease from 28 days in 2017 to a minimum of 23 days in 2019. A subsequent expansion in the processing period occurred, returning to 27 days by 2021, which aligns with the observed decline in turnover ratios. By September 30, 2022, the processing period was reduced to 25 days, suggesting a restoration of efficiency in inventory movement.
AI Ask an analyst for more
Average Receivable Collection Period
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Receivables turnover | 12.93 | 11.78 | 13.71 | 14.50 | 14.84 | 14.86 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average receivable collection period1 | 28 | 31 | 27 | 25 | 25 | 25 | |
| Benchmarks (no. days) | |||||||
| Average Receivable Collection Period, Competitors2 | |||||||
| Abbott Laboratories | 52 | 55 | — | — | — | — | |
| Elevance Health Inc. | 19 | 18 | — | — | — | — | |
| Intuitive Surgical Inc. | 55 | 50 | — | — | — | — | |
| Medtronic PLC | 64 | 66 | — | — | — | — | |
| UnitedHealth Group Inc. | 20 | 18 | — | — | — | — | |
| Average Receivable Collection Period, Sector | |||||||
| Health Care Equipment & Services | 25 | 25 | — | — | — | — | |
| Average Receivable Collection Period, Industry | |||||||
| Health Care | 44 | 46 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Average receivable collection period = 365 ÷ Receivables turnover
= 365 ÷ 12.93 = 28
2 Click competitor name to see calculations.
The analysis of operating activity ratios indicates a period of relative stability followed by a decline in efficiency regarding the collection of receivables, with a modest recovery observed in the final year of the period.
- Receivables Turnover
- A consistent downward trend was observed from September 30, 2017, through September 30, 2021, with the ratio decreasing from 14.86 to 11.78. This decline suggests a reduction in the frequency with which accounts receivable were converted into cash. This trend reversed in 2022, as the turnover ratio increased to 12.93, indicating an improvement in asset utilization.
- Average Receivable Collection Period
- The collection period remained constant at 25 days from 2017 to 2019. Beginning in 2020, the period lengthened to 27 days and peaked at 31 days in 2021, reflecting a slower recovery of credit sales. By September 30, 2022, the period decreased to 28 days, signaling a partial return toward historical efficiency levels.
AI Ask an analyst for more
Operating Cycle
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Average inventory processing period | 25 | 27 | 25 | 23 | 27 | 28 | |
| Average receivable collection period | 28 | 31 | 27 | 25 | 25 | 25 | |
| Short-term Activity Ratio | |||||||
| Operating cycle1 | 53 | 58 | 52 | 48 | 52 | 53 | |
| Benchmarks | |||||||
| Operating Cycle, Competitors2 | |||||||
| Abbott Laboratories | 170 | 157 | — | — | — | — | |
| Intuitive Surgical Inc. | 216 | 172 | — | — | — | — | |
| Medtronic PLC | 230 | 216 | — | — | — | — | |
| Operating Cycle, Sector | |||||||
| Health Care Equipment & Services | 37 | 36 | — | — | — | — | |
| Operating Cycle, Industry | |||||||
| Health Care | 90 | 92 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Operating cycle = Average inventory processing period + Average receivable collection period
= 25 + 28 = 53
2 Click competitor name to see calculations.
The operating cycle exhibits a pattern of relative stability with a notable peak in 2021, followed by a correction toward baseline levels in 2022.
- Average Inventory Processing Period
- The duration required to process inventory fluctuated within a narrow range of 23 to 28 days. A period of increased efficiency was observed in 2019, when the period reached its minimum of 23 days, before stabilizing at 25 days by the end of the observed period in 2022.
- Average Receivable Collection Period
- The collection of receivables remained constant at 25 days from 2017 through 2019. An upward trend emerged starting in 2020, peaking at 31 days in 2021. Although this figure decreased to 28 days in 2022, it remains elevated compared to the levels maintained during the initial three years of the analysis.
- Operating Cycle
- The total operating cycle mirrored the movements of its underlying components, fluctuating between a minimum of 48 days in 2019 and a maximum of 58 days in 2021. The expansion of the cycle in 2021 was primarily driven by the increase in the receivable collection period rather than inventory delays. By 2022, the operating cycle returned to 53 days, reverting to the level observed at the start of the analyzed period in 2017.
AI Ask an analyst for more
Average Payables Payment Period
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Payables turnover | 5.73 | 5.45 | 5.83 | 6.15 | 6.09 | 5.85 | |
| Short-term Activity Ratio (no. days) | |||||||
| Average payables payment period1 | 64 | 67 | 63 | 59 | 60 | 62 | |
| Benchmarks (no. days) | |||||||
| Average Payables Payment Period, Competitors2 | |||||||
| Abbott Laboratories | 88 | 87 | — | — | — | — | |
| Elevance Health Inc. | 49 | 48 | — | — | — | — | |
| Intuitive Surgical Inc. | 26 | 25 | — | — | — | — | |
| Medtronic PLC | 82 | 73 | — | — | — | — | |
| UnitedHealth Group Inc. | 50 | 48 | — | — | — | — | |
| Average Payables Payment Period, Sector | |||||||
| Health Care Equipment & Services | 53 | 51 | — | — | — | — | |
| Average Payables Payment Period, Industry | |||||||
| Health Care | 63 | 63 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Average payables payment period = 365 ÷ Payables turnover
= 365 ÷ 5.73 = 64
2 Click competitor name to see calculations.
The analysis of short-term operating activity reveals a stable yet fluctuating pattern in the management of accounts payable between 2017 and 2022. The relationship between payables turnover and the average payment period demonstrates a consistent inverse correlation, reflecting a disciplined approach to supplier credit management.
- Payables Turnover
- The payables turnover ratio experienced a gradual increase from 5.85 in 2017 to a peak of 6.15 in 2019, indicating a more frequent settlement of obligations during this period. Subsequently, a downward trend occurred, with the ratio reaching its lowest point of 5.45 in 2021. A moderate recovery was observed in 2022, where the ratio rose to 5.73, suggesting a return toward historical averages.
- Average Payables Payment Period
- The average time taken to settle payables fluctuated within a narrow range of 8 days. The payment period decreased from 62 days in 2017 to a low of 59 days in 2019, coinciding with the peak in turnover. This trend reversed after 2019, with the payment period extending to 63 days in 2020 and peaking at 67 days in 2021. By 2022, the period contracted to 64 days.
The extension of the payment period between 2020 and 2021 suggests a strategic shift toward maximizing working capital by deferring cash outflows. The subsequent reduction in the payment period and the corresponding increase in turnover in 2022 indicate a stabilization of credit terms and liquidity management. Overall, the consistency of these metrics suggests that the company maintains a predictable and sustainable relationship with its vendors.
AI Ask an analyst for more
Cash Conversion Cycle
| Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | ||
|---|---|---|---|---|---|---|---|
| Selected Financial Data | |||||||
| Average inventory processing period | 25 | 27 | 25 | 23 | 27 | 28 | |
| Average receivable collection period | 28 | 31 | 27 | 25 | 25 | 25 | |
| Average payables payment period | 64 | 67 | 63 | 59 | 60 | 62 | |
| Short-term Activity Ratio | |||||||
| Cash conversion cycle1 | -11 | -9 | -11 | -11 | -8 | -9 | |
| Benchmarks | |||||||
| Cash Conversion Cycle, Competitors2 | |||||||
| Abbott Laboratories | 82 | 70 | — | — | — | — | |
| Intuitive Surgical Inc. | 190 | 147 | — | — | — | — | |
| Medtronic PLC | 148 | 143 | — | — | — | — | |
| Cash Conversion Cycle, Sector | |||||||
| Health Care Equipment & Services | -16 | -15 | — | — | — | — | |
| Cash Conversion Cycle, Industry | |||||||
| Health Care | 27 | 29 | — | — | — | — | |
Based on: 10-K (reporting date: 2022-09-30), 10-K (reporting date: 2021-09-30), 10-K (reporting date: 2020-09-30), 10-K (reporting date: 2019-09-30), 10-K (reporting date: 2018-09-30), 10-K (reporting date: 2017-09-30).
1 2022 Calculation
Cash conversion cycle = Average inventory processing period + Average receivable collection period – Average payables payment period
= 25 + 28 – 64 = -11
2 Click competitor name to see calculations.
The analysis of short-term operating activity between 2017 and 2022 reveals a consistently negative cash conversion cycle, indicating a highly efficient working capital model where supplier credit effectively finances the operational requirements of the business.
- Average Inventory Processing Period
- Inventory turnover remained relatively stable throughout the period, fluctuating within a narrow range of 23 to 28 days. A minimum was observed in 2019 at 23 days, while the period concluded at 25 days in 2022, suggesting a consistent and controlled movement of goods.
- Average Receivable Collection Period
- The collection period demonstrated high stability at 25 days from 2017 through 2019. An upward trend emerged in 2020, peaking at 31 days in 2021 before moderating to 28 days in 2022, indicating a slight expansion in the time required to convert receivables into cash toward the end of the period.
- Average Payables Payment Period
- The payment period consistently served as the dominant component of the operating cycle, remaining above 59 days for the duration of the analysis. The period peaked at 67 days in 2021, reflecting an increased reliance on supplier financing during that fiscal year.
- Cash Conversion Cycle
- The overall cash conversion cycle remained negative, ranging from -8 to -11 days. This negative value is sustained by a payables payment period that significantly exceeds the combined duration of the inventory processing and receivable collection periods. The cycle reached its most efficient points in 2019, 2020, and 2022, each recording a cycle of -11 days.
AI Ask an analyst for more